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We assessed the quantitative contribution of pig farm-
ing to antimicrobial resistance in the commensal flora of pig
farmers by comparing 113 healthy pig farmers from the
major French porcine production areas to 113 nonfarmers,
each matched for sex, age, and county of residence. All
reported that they had not taken antiimicrobial agents with-
in the previous month. Throat, nasal, and fecal swabs were
screened for resistant microorganisms on agar containing
selected antimicrobial agents. Nasopharyngeal carriage of
Staphylococcus aureus was significantly more frequent in
pig farmers, as was macrolide resistance of S. aureus from
carriers. Nongroupable streptococci from the throat were
more resistant to the penicillins in pig farmers. The intestin-
al isolation of enterococci resistant to erythromycin or van-
comycin was not significantly higher in pig farmers in
contrast to that of enterobacteria resistant to nalidixic acid,
chloramphenicol, tetracycline, and streptomycin. Preva-
lence of resistance in predominant fecal enterobacteria
was also significantly higher in pig farmers for cotrimoxa-
zole, tetracycline, streptomycin, and nalidixic acid. We
determined a significant association between pig farming
and isolation of resistant commensal bacteria.
H
igher prevalence of antimicrobial-resistant bacteria in
commensal flora contributes to the general increase
and dissemination of bacterial resistance worldwide (1,2)
and can be a source of resistance genes for respiratory
pathogens such as Streptococcus pneumoniae (3) and
intestinal pathogens such as Shigella (4) or Salmonella
(5,6). Antimicrobial treatments are major factors for selec-
tion of resistance in the commensal flora of humans (7).
Industrial animal farming is also associated with large-
scale antimicrobial use (8), which leads to a high level of
colonization of animals with antimicrobial-resistant bacte-
ria that can then contaminate the food and, in turn, humans
(9,10). Farmers are more likely to acquire enteric antimi-
crobial-resistant bacteria from food-producing animals,
even if not treated with antimicrobial agents themselves
(11–14). However, this link has never been quantitatively
assessed. Antimicrobial resistance in nasal and pharyngeal
commensal strains might possibly be affected in the same
manner, and this hypothesis has also not been investigated.
We thus designed an exposed-nonexposed epidemiologic
study to determine the association between contact with
animals in pig-raising farms and isolation of antimicrobial-
resistant nasal, pharyngeal, and intestinal commensal
microorganisms.
Methods
Participants
The study population was composed of members of the
Mutualité Sociale Agricole (MSA), a health insurance sys-
tem for workers in agriculture and related services. We
identified pig farmers as an exposed group and nonfarmers
(such as those working at banks or in insurance services) as
a nonexposed group. The sample size was calculated
according to results on the prevalence of antimicrobial
resistance in the fecal flora of French residents (15) to
ensure that, for most markers measured, detection of a 10%
difference in the exposed group would be found with a
power of 80% and an α risk of 5%. Pig farmers were cho-
sen among those working in large, exclusively pig farms
(>84 pigs) and contacted during the yearly MSApreventive
medicine visits to obtain permission for participation. One
pig farmer per farm was randomly selected to fill a panel of
20 in each of the seven major French porcine production
areas. 
One nonfarmer control, matched for sex, age, and coun-
ty of residence, was selected for each pig farmer and
approached similarly. Nonfarmers were not living or work-
ing on a farm, in a slaughterhouse, or in the pharmaceutical
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Persons included in the study were judged healthy by
physical examination, had no gastrointestinal symptoms or
throat pain at inclusion, and reported that they had not
been hospitalized or taken antimicrobial agents within the
previous month. All study participants were enrolled with-
in 3 months. Study participants’ antimicrobial use in the 6
months preceding the study was retrospectively estimated
from the MSA reimbursement database and converted to
defined daily doses, as described (16). In cases in which
methicillin-resistant Staphylococcus aureus (MRSA) was
isolated, participants were further interviewed for hospital-
ization and contacts with hospitalized patients and health-
care workers during the previous year, as described (17).
Occurrence and type of contact with pigs and contact pre-
cautions used in farms were documented in pig farmers
with a standardized questionnaire. This study was per-
formed in agreement with legal and ethical French regula-
tory procedures. 
Specimens Obtained 
Study participants were asked to bring fresh stool sam-
ples in sterile, closed cups. A sterile cotton swab was
immersed in the sample. No procedure was implemented
to ensure that participants brought their own stool speci-
mens. They likely did, however, since participants were
contacted during the yearly MSApreventive medicine vis-
its by the practitioner with whom they had an established
confidential relationship. Nasal swabs were inserted
(1 cm) successively in both nares and rotated three times
for 10 to 15 s. Pharyngeal samples were obtained by firm-
ly pressing a swab over the tonsils and the posterior pha-
ryngeal wall, and avoiding touching the jaws, teeth, or
gingival when withdrawing the swab. All swabs were
extemporaneously squeezed in sterile brain-heart infusion
broth (BioMérieux, Marcy-l’Etoile, France) with 10%
glycerol, immerged in liquid nitrogen within 6 hours, and
stored at –80°C until processing. 
Detection of Microbial Isolates
One hundred microliter–aliquots of all broth samples
were plated as follows. For nasal samples, isolation of S.
aureus  was performed on Chapman agar (BioMérieux).
Antimicrobial susceptibility of one isolate per participant
was determined by using the disk diffusion technique (18).
For the pharyngeal samples, isolation of Streptococcus
pneumoniae and β-hemolytic streptococci was performed
on 5% sheep blood Columbia agar; isolation of
Haemophilus influenzae was performed on chocolate agar,
Staphylococcus aureus on Chapman agar, and yeast on
Chromagar (all BioMérieux). Isolation of antimicrobial-
resistant nongroupable streptococci was performed on 5%
sheep blood Columbia agar supplemented with nalidixic
acid and colistin. Antimicrobial-resistant nongroupable
streptococci were detected on the same medium, supple-
mented with ampicillin (4 mg/L) or erythromycin (1
mg/L). For feces, aliquots were plated on Chromagar,
Cetrimide (Bio-Mérieux), and Chapman agar for detection
of yeasts, Pseudomonas aeruginosa, and S. aureus, respec-
tively. Detection of enterococci of any resistance pheno-
type and of those resistant to erythromycin was performed
on Bile-Esculin-agar (BEA) (BioMérieux) free of antimi-
crobial agents or supplemented with 5 mg erythromycin/L,
respectively. Detection of vancomycin-resistant enterococ-
ci (VRE) was performed on BEA supplemented with 10
mg vancomycin/L after an enrichment step of 18 hours in
broth containing 1 mg vancomycin/L, as described (19,20).
The mechanism of vancomycin resistance was determined
by polymerase chain reaction analysis, as described (21).
Carriage of resistant enterobacteria was detected by using
two separate procedures, as described (22), with modifica-
tions. In the first, designed to explore the subdominant
flora, 0.1 mL of broth was plated on Drigalski agar supple-
mented with ampicillin (10 mg/L), ceftazidime (2 mg/L),
streptomycin (20 mg/L), kanamycin (20 mg/L), chloram-
phenicol (20 mg/L), tetracycline (10 mg/L), or nalidixic
acid (50 mg/L), as described (15). Escherichia coli of
known susceptibility were used as the control. One of 10
positive plates was selected for quality control, and one
colony was selected for antimicrobial susceptibility testing.
A study participant was defined as colonized in the sub-
dominant fecal flora with enterobacteria resistant to a given
antimicrobial agent when at least one colony grew from the
plate containing the corresponding antimicrobial agent. 
In the second procedure, designed to explore the pre-
dominant fecal flora, Drigalski agar plates without antimi-
crobial agents were spread with 0.1 mL of broth culture.
Five colonies were randomly selected. Those identified as
E. coli were tested for antimicrobial susceptibility. Astudy
participant was defined as colonized in the predominant
flora by E. coli resistant to a given antimicrobial agent
when at least one resistant strain was recovered from the
feces by using this second procedure. 
Statistical Analysis
The prescribed defined daily doses of an antimicrobial
agent and the number of participants for whom antimicro-
bial agents had been ordered within the previous 6 months
were compared between pig farmers and nonfarmers by
using the Student t test for matched data. Differences
between groups for carriage of nasal, pharyngeal, and fecal
microbial species were analyzed by calculating matched
prevalence ratios (PR) (23). For comparing antimicrobial-
resistant phenotypes of S. aureus, nongroupable strepto-
cocci,  E. coli, enterococci, and enterobacteria from pig
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used, since these comparisons were performed on sub-
groups composed of only the carriers of the species with
resistant clones that we examined. (For instance, rates of
carriage of resistant enterobacteria were composed from
subgroups of those actually carrying enterobacteria.)
Because this analysis was performed only for carriers, a
comparison in terms of age, sex, and location was per-
formed to assess that pig farmers and nonfarmer carrier
subgroups were comparable for these variables. Frequency
of co-resistance to ampicillin, streptomycin, and trimetho-
prim-sulfamethoxazole in predominant strains of E. coli
was used as a marker for multiple resistance and compared
between groups (23). In analyzing data, we did not adjust
for making multiple comparisons (24) since adjusting
remains controversial (25,26), particularly for actual
observations on nature (27). The association between iso-
lation of resistant strains and specific farming activities
and the size of farms was assessed by chi-square analysis. 
Results
We matched 113 exposed pig farmers with 113 nonex-
posed nonfarmers. The overall male-to-female ratio was
6.1, and mean age was 37.8 years (range 21–72). Mean
previous time in the professional position occupied at the
time of the study was 9.7 ± 1.9 and 13.0 ± 1.6 years for pig
farmers and nonfarmers, respectively (p < 0.01). 
Health insurance reimbursement data showed that
antimicrobial agents had been prescribed in the month pre-
ceding the study for two pig farmers (one with macrolide
and one with broad-spectrum penicillin 24 and 28 days
before participation, respectively) and three nonfarmers
(one with oral cephalosporin, one with penicillinase-resist-
ant penicillin, and one with tetracycline 3, 10, and 24 days
before participation, respectively). However, because of
the retrospective nature of this analysis, the low number of
participants, the nearly even distribution between pig
farmers and nonfarmers, and the fact that reimbursement
data are not a formal proof that antimicrobial agents were
actually taken, these five persons were included in further
analysis. Neither overall, nor class-specific antimicrobial
prescriptions during the 6 months preceding participation
in the study were significantly different between pig farm-
ers and nonfarmers (Table 1). Prevalence of nasal or pha-
ryngeal isolation of S. aureus was significantly higher in
pig farmers (PR 1.85; confidence intervals [CI] 1.26 to
2.71]; p < 0.01) (Table 2). Isolation of erythromycin-resist-
ant strains was significantly more frequent among S.
aureus pig farmer carriers than among nonfarmer carriers
(PR 9.72; CI 2.53 to 37.30; p < 0.01). Moreover, 31 (87%)
of 36 macrolide-resistant S. aureus isolates from pig farm-
ers were cross-resistant to lincosamides. Five pig farmers,
but no nonfarmers, had MRSA (not significant). Analysis
of the antimicrobial-susceptibility profile of these strains
showed that two were resistant to at least one macrolide
antimicrobial agent, four were resistant to aminoglyco-
sides, and four were resistant to pefloxacin. Three of the
MRSA carriers had been hospitalized within the 2 years
preceding the study, including one within the previous
year. The two other farmers had not been hospitalized but
had visited outpatient clinics for medical problems within
the year preceding the study.
Prevalence of pharyngeal isolation of Streptococcus
pneumoniae, H. influenzae, and β-hemolytic streptococci
was low and did not differ significantly between groups
(Table 3). One pig farmer carried yeast (Candida albi-
cans). Isolation of nongroupable streptococci was frequent
and not significantly different between groups, but that of
nongroupable streptococci resistant to ampicillin was sig-
nificantly more frequent in pig farmers than in nonfarmers
(PR 2.02; CI 1.32 to 3.09; p < 0.01). Prevalence of fecal
enterococci was not significantly different between groups
nor was isolation of enterococci resistant to erythromycin
or vancomycin (Table 4). In all, 16 VRE were isolated
including 2 VanA-type Enterococcus faecium, along with
11 E. gallinarum and 3 E. casseliflavus of VanC phenotype
and genotype. Nearly all participants carried enterobacte-
ria: 103 (94.5%) of 109 pig farmers and 100 (91.7%) of
109 nonfarmers (PR 1.03; CI 0.96 to 1.10; not significant).
Isolation of enterobacteria resistant to nalidixic acid (PR
7.12; CI 2.20 to 23.0; p < 0.01), chloramphenicol (PR 2.08;
CI 1.17 to 3.68); p < 0.01), tetracycline (PR 1.65; CI 1.27
to 2.13; p < 0.01), and streptomycin (PR 1.40; CI 1.01 to
1.95; p < 0.01) was significantly more frequent in pig
Antimicrobial Resistance in Pig Farmers
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Table 1. Total defined daily doses (DDD) of various classes of antimicrobial agents during the 6 months preceding participation in 
study
a 
Total DDD (no. participants
b) 
Antimicrobial agent  Pig farmers  Nonfarmers 
Penicillins (narrow-spectrum, broad-spectrum, and penicillinase-resistant)  138  (9)  132  (9) 
Cephalosporins  53  (7)  83  (9) 
Macrolides and lincosamides  67  (9)  35  (6) 
Others  15  (3)  67  (2) 
Total  273  (25)
c  317  (19)
c 
aAs determined by health insurance reimbursements to pig farmers and nonfarmers. 
bWho used any given type of antimicrobial agent. 
cSome persons had multiple treatments. farmer carriers of enterobacteria than in nonfarmer carri-
ers. Regarding the predominant flora, the most frequent
species isolated were Escherichia coli (917/995; 92.2%)
followed by Hafnia alvei (48/995; 4.8%) and Citrobacter
freundii (11/995; 1.1%) with no significant between-group
differences. The prevalence of isolation of E. coli resistant
to cotrimoxazole (PR 3.02; CI 1.68 to 5.44; p < 0.01),
tetracycline (PR 2.22; CI 1.48 to 3.32; p < 0.01), strepto-
mycin (PR 1.40; CI 1.01 to 1.95; p = 0.04), or nalidixic
acid (PR not calculable; p < 0.01) was significantly higher
in pig farmers carrying E. coli than in nonfarmers (Table
4). In all instances in which subgroups of pig farmers and
nonfarmers were compared, no significant between-group
difference emerged in terms of age, sex, and county of res-
idence. Prevalence of co-resistance to ampicillin, strepto-
mycin, and cotrimoxazole was also significantly higher in
E. coli from pig farmers (24%, 24/100) than from non-
farmers (12.2%, 12/98) (PR 1.96; CI 1.04 to 3.70; p =
0.03). No strains resistant to ceftazidime were isolated. No
strains of Clostridium difficile, Pseudomonas aeruginosa,
or Staphylococcus aureus were isolated from the feces of
any study participant. Prevalence of yeast was not signifi-
cantly different between pig farmers and nonfarmers, and
the species were evenly distributed (Table 4).
Most pig farmers had several professional activities.
Only a few farmers used isolation precautions (Table 5).
We found no statistical association between professional
activity or use of masks and gloves and the prevalence of
resistant bacteria. By contrast, prevalence of nasal isola-
tion of S. aureus resistant to macrolides increased signifi-
cantly, from 33% (5/15) in pig farmers working in farms
raising 84–180 swine, to 70% (7/10), 92% (11/12), and
100% (13/13) in those working in farms raising 181–270,
271–399, and >400 swine, respectively (chi-square linear
slope; p < 0.01).
Discussion
Our results showed that the prevalence of antimicrobial
drug resistance in bacteria from the nasal, pharyngeal, and
fecal flora was higher in pig farmers than in nonfarmers.
With a few exceptions, pig farmers and nonfarmers had not
taken antimicrobial agents during the month preceding the
study and had not been differentially exposed to such
agents during the previous 6 months. That E. coli (11–13)
RESEARCH
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Table 2. Nasopharyngeal isolation of Staphylococcus aureus with various susceptibility to antimicrobial agents in pig farmers and 
nonfarmers
a 
Prevalence no. (%) 
Type of S. aureus  Pig farmers  Nonfarmers  Prevalence ratio  95% CI  p value 
Any  50/112  (44.6)  27/122  (24.1)  1.85  1.26 to 2.71  <0.01 
Resistant to 
Methicillin   5
a/50  (10.0)  0/27      NA
c  0.59 
Macrolides   36/50  (72.0)  2/27  (7.4)  9.72  2.53 to 37.30  <0.01 
Gentamicin   10/50  (20.0)  0/27    NA  NA  0.11 
Pefloxacin   8/50  (16.0)  1/27  (3.7)  4.32  0.57 to 32.75  0.22 
aMatched nasal samples were available for 112 pig farmer–nonfarmer pairs only. 
bIn
 addition to being resistant to methicillin, two strains were resistant to at least one macrolide antibiotic (two were resistant [R] to erythromycin, lincomycin, and 
pristinamycin; 1 susceptible [S] to erythromycin only; and one susceptible to pristinamycin only), 4 strains were R to aminoglycosides (2 were RRS and 2 RRR to 
kanamycin, tobramycin, and gentamicin, respectively). Four strains were resistant to pefloxacin. 
cNA, not applicable. 
Table 3. Pharyngeal isolation of selected microorganisms in pig farmers and nonfarmers
a,b 
Prevalence, no. (%) 
Microorganisms  Pig farmers  Nonfarmers  Prevalence ratio  95% CI  p value 
Streptococcus pneumoniae  0/112  (0)  3/112  (2.7)  NA  NA  0.25 
Haemophilus influenzae  6/112  (5.4)  5/112  (4.5)  1.20  0.38 to 3.82  1.00 
Enterobacteria  1/112  (0.9)  2/112  (1.8)  0.50  0.05 to 5.44  1.00 
Yeasts
c  1/112  (0.9)  0/112    NA  NA  0.25 
β-hemolytic streptococci
d   11
e/112  (9.8)  9
f/112  (8.0)  1.22  0.53 to 2.83  0.82 
NGS
g               
Any  108/112  (96.4)  100/112  (89.3)  1.08  1.00 to 1.16  0.06 
Resistant to               
Ampicillin   48/108  (44.4)  22/100  (22.0)  2.02  1.32 to 3.09  <0.01 
Macrolides   108/108  (100.0)  100/100  (100.0)  NA  NA  1.00 
aMatched pharyngeal samples were available for 112 pig farmer–nonfarmer pairs. 
bCI, confidence interval; NA, not applicable. 
cCandida albicans. 
dSeveral species were present in some study participants. 
eGroup A streptococcus:1, group C: 5, S. anginosus: 3, S. intermedius: 1, S. constellatus: 4. 
fGroup A streptococcus: 1, group C: 5, S. anginosus: 3, S. intermedius: 1, S. constellatus: 3. 
gNongroupable streptococci. and enterococci (14) are significantly more resistant in per-
sons working in farms or slaughterhouses than in urban
residents had been reported, but a potential role of antimi-
crobial treatments in these workers could not be excluded
and the increased prevalence of carriage of resistant organ-
isms had not been quantified.
The prevalence of S. aureus nasal carriage in nonfarm-
ers was similar to that reported previously in the general
population (28), which suggests that the higher isolation
rate in pig farmers was due to their work environment.
This hypothesis was further supported by the increased
resistance to macrolides (still the fourth most common
class of antimicrobial agents used in food production [8])
of S. aureus isolates from pig farmers and the link between
this resistance and the size of the farm. Why the isolation
rate of S. aureus was higher in pig farmers remains unclear.
Several hypotheses, including high transfer of animal spe-
cific clones, should be raised and investigated.
In the pharynx, ampicillin resistance of nongroupable
streptococci in pig farmers may contribute to further trans-
fer of β-lactam resistance to Streptococcus pneumoniae by
transformation (29). In the feces, antimicrobial drug resist-
ance in enterobacteria was also greater in pig farmers for
four of eight markers tested in the subdominant flora, and
for four of nine markers in the predominant flora.
Resistance in E. coli was close to that of healthy partici-
pants from developing countries (22). The prevalence of
resistance in enterobacteria from the subdominant flora of
our nonfarmers was lower than that in participants of the
only study published that used the same methods; howev-
er, that study included mostly laboratory workers (A.
Andremont, pers. comm.), who are known to be more col-
onized by resistant enterobacteria than are urban and rural
dwellers (30). The rate of VRE colonization that we
observed differed from that reported in France (31), which
might be due to the enrichment step we used; however, the
Antimicrobial Resistance in Pig Farmers
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Table 4. Fecal isolation of selected microorganisms in pig farmers and in nonfarmers  
Prevalence no. (%) 
Microorganisms  Pig farmers  Nonfarmers  Prevalence ratio  95 % CI  p value 
Enterococci           
Any  71/109  (65.1)  80/109  (73.4)  0.89  0.75 to 1.05  0.21 
Resistant to 
Erythromycin   38/71  (53.5)  46/80  (57.5)  0.93  0.70 to .24  0.62 
Vancomycin   6
b/71  (8.5)  10
c/80  (12.5)  0.68  0.26 to 1.77  0.42 
Enterobacteria
d 
Any  103/109  (94.5)  100/109  (91.7)  1.03  0.96 to 1.10  0.58 
Resistant to 
Ampicillin   68/103  (66.0)  55/100  (55.0)  1.20  0.96 to 1.50  0.11 
Ceftazidime   0    0    NA
e  NA  NA 
Streptomycin   69/103  (67.0)  48/100  (48.0)  1.40  1.09 to 1.78  <0.01 
Kanamycin   29/103  (28.2)  23/100  (23.0)  1.22  0.76 to 1.96  0.40 
Gentamicin   10/103  (9.7)  3/100  (3.0)  3.24  0.92 to 11.42  0.05 
Chloramphenicol   30/103  (29.1)  14/100  (14.0)  2.08  1.17 to 3.68  <0.01 
Tetracycline   73/103  (70.9)  43/100  (43.0)  1.65  1.27 to 2.13  <0.01 
Nalidixic acid   22/103  (21.4)  3/100  (3.0)  7.12  2.20 to 23.0  <0.01 
Escherichia coli
f 
Any  100/109  (91.7)  98/109  (89.9)  1.02  0.94 to 1.10  0.64 
Resistant to 
Ampicillin   36/100  (36.0)  34/98  (34.7)  1.04  0.71 to 1.51  0.85 
Ceftazidime   0    0    NA  NA  NA 
Streptomycin   50/100  (50.0)  35/98  (35.7)  1.40  1.01 to 1.95  0.04 
Kanamycin   10/100  (10.0)  12/98  (12.2)  0.82  0.37 to 1.80  0.62 
Gentamicin   2/100  (2.0)  0    NA  NA  0.99 
Chloramphenicol   11/100  (11.0)  9/98  (9.2)  1.20  0.52 to 2.76  0.67 
Tetracycline   52/100  (52.0)  23/98  (23.5)  2.22  1.48 to 3.32  <0.01 
Cotrimoxazole  37/100  (37.0)  12/98  (12.2)  3.02  1.68 to 5.44  <0.01 
Nalidixic acid   11/100  (11.0)  0    NA  NA  <0.01 
Staphylococcus aureus  4/109  (3.7)  2/109  (1.8)  2.0  0.37 to 10.69  0.68 
Yeasts  19
g/109  (17.4)  18
h/109  (17.4)  1.06  0.59 to 1.90  1.00 
aMatched fecal samples were available for 109 pig farmers and nonfarmer pairs only. 
bEnterococcus faecium: 0, E. gallinarum: 6. 
cE. faecium: 2, E. gallinarum: 5, E. casseliflavus: 3. 
dUsing direct plating plating on Drigalski agar without or with antimicrobial agents (first technique, see Methods). 
eNA, not applicable. 
fFrom the predominant fecal flora (second technique, see Methods). 
gCandida albicans: 1, Geotrichum sp.: 15, C. glabrata: 2, Rhodolulora sp.: 1. 
hC. albicans: 2, Geotrichum sp.: 14, Saccharomyces cerevesia: 2. 
 rate of VRE colonization did not differ between farmers
and nonfarmers. This finding suggests that the 1997 ban
(32) of avoparcin, a glycopeptide previously used as a
growth promoter, was effective. Although specific infor-
mation on avoparcin is lacking, 145 tons of antimicrobial
agents were used globally in France in 1998 in pig raising,
including 70 mg of growth additive per kilogram of pork
meat produced (33).
Three possible explanations may explain why isolation
of resistant bacteria in pig farmers was higher than in non-
farmers. First, farmers may come in contact with more
antimicrobial-resistant bacteria from pigs; these bacteria
are then transferred to the farmers. Second, farmers may be
in frequent contact with antimicrobial agents themselves
or antimicrobial residues that are given to the pigs in the
workplace. The third possibility is that farmers receive
more antimicrobial agents for other, i.e., medical, reasons.
The first of these possibilities appears most likely because
1) farmers used very few precautions during contact with
animal feces, 2) antimicrobial exposure is a well-known
risk factor for intestinal yeast colonization (34,35), and
yeast colonization in both groups was low, and 3) antimi-
crobial prescriptions were not significantly different
between pig farmers and nonfarmers during the previous 6
months. 
We did not assess the use of antimicrobial agents for
animals in each of the 113 farms where pig farmers
worked. However, 1,364 tons of antimicrobial agents were
sold in France in 1999 for veterinary medicinal use. Of
these, tetracycline, cotrimoxazole, and β-lactams together
accounted for 79.5% (8), a finding compatible with the
high resistance rates found in pig farmers. However, we
could not assess the exact cause of the high antimicrobial
resistance rates in farmers. Determining the exact cause
may not be as important as the fact that these people are
colonized with a much higher rate of resistant bacteria.
Further studies will need to be undertaken to identify the
cause of this phenomenon.
Food products are a source of resistant bacteria (9,10).
We minimized the risk that differences in food intake
caused the higher prevalence of resistance in pig farmers
by matching pig farmers with nonfarmers by age, sex, and
county of residence. Children can be a source of resistant
bacteria in households (36) and thus might be a confound-
ing factor if the number of children was greater in pig
farmer families than in nonfarmer families. However, this
factor was not documented in the study questionnaire and
thus could not be investigated.
Some inherent limitations of cross-sectional studies
invite cautious assessments of our results. The lack of pre-
exposure data on resistance and the general design of the
study preclude determining a causal relationship between
exposure and acquired resistance. However, the observa-
tion we made indicates that professional pig farming is sig-
nificantly associated with isolation of antimicrobial-
resistant commensal species. The minimal use of contact
precautions by pig farmers may have further increased this
risk, but the study was not designed to assess the efficacy
of contact precautions, and thus no recommendations can
be drawn in this matter.
Pigs could be raised with considerably fewer antimi-
crobial agents than currently used, and many animals can
be raised with little or no exposure to such drugs at all
(37). However, antimicrobial agents will still be used to
treat sick animals. Additional studies are needed to evalu-
ate the consequences of isolating resistant bacteria in
farmers and, if necessary, design appropriate preventive
measures.
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Antibiotic administration to animals  112 (99)  4 (3.5)  9 (8.0) 
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primary research interest is the surveillance of bacterial resist-
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References
1. Levy SB. Ecology of antibiotic resistance determinants. In: Press
CSHL, editor. Antibiotic resistance genes: ecology, transfer and
expression. New York: Cold Spring Harbor Press; 1986. p. 17–30.
2. Summers AO. Generally overlooked fundamentals of bacterial genet-
ics and ecology. Clin Infect Dis 2002;34(Suppl 3):S85–92.
3. Dowson C, Coffey T, Spratt B. Origin and molecular epidemiology of
penicillin-binding-protein-mediated resistance to beta-lactam antibi-
otics. Trends Microbiol 1994;2:361–6.
4. Tauxe RV, Cavanagh TR, Cohen ML. Interspecies gene transfer in
vivo producing an outbreak of multiply resistant shigellosis. J Infect
Dis 1989;160:1067–70.
5. Hunter JE, Shelley JC, Walton JR, Hart CA, Bennett M. Apramycin
resistance plasmids in Escherichia coli: possible transfer to
Salmonella typhimurium in calves. Epidemiol Infect
1992;108:271–8.
6. Gast RK, Stephens JF. In vivo transfer of antibiotic resistance to a
strain of Salmonella arizonae. Poult Sci 1986;65:270–9.
7. Cohen ML. Epidemiology of drug resistance: implications for a post-
antimicrobial era. Science 1992;257:1050–5.
8. Moulin G. Surveillance of antimicrobial consumption : activities in
France (Agence Nationale du Médicament Vétérinaire). In: 2nd
International Conference of the Office International des Epizoosties,
2001; Paris; 2001.
9. Corpet DE. Antibiotic resistance from food. N Engl J Med
1988;318:1206–7.
10. Perrier-Gros-Claude J, Courrier P, Bréard J, Vignot J, Masseront T,
Garin D, et al. Entérocoques résistants aux glycopeptides dans les
viandes. Bulletin Epidemiologique Hebdomadaire 1998:50–1.
11. Marshall B, Petrowski D, Levy S. Inter- and intraspecies spread of
Escherichia coli in a farm environment in the absence of antibiotic
usage. Proc Natl Acad Sci U S A 1990;87:6609–13.
12. Nijsten R, London N, van den Bogaard A, Stobberingh E. Resistance
in faecal Escherichia coli isolated from pigfarmers and abattoir work-
ers. Epidemiol Infect 1994;113:45–52.
13. Nijsten R, London N, van den Bogaard A, Stobberingh E. Antibiotic
resistance among Escherichia coli isolated from faecal samples of pig
farmers and pigs. J Antimicrob Chemother 1996;37:1131–40.
14. Stobberingh E, van den Bogaard A, London N, Driessen C, Top J,
Willems R. Enterococci with glycopeptide resistance in turkeys,
turkey farmers, turkey slaughterers, and (sub)urban residents in the
south of The Netherlands: evidence for transmission of vancomycin
resistance from animals to humans? Antimicrob Agents Chemother
1999;43:2215–21.
15. Chachaty E, Youssef MT, Bourneix C, Andremont A. Shedding of
antibiotic-resistant members of the family Enterobacteriaceae in
healthy residents of France and Jordan. Res Microbiol
1995;146:175–82.
16. ATC i. ATC index with DDDs. Oslo: WHO Collaborating Centre for
Drug Statistics Methodology; 1999.
17. Bellon O, Cavallo JD, Roussel-Delvallez M, Péan Y, Weber P.
Antibiotic resistance outside the hospital. La Lettre de l’Infectiologue
2000;25:158–66.
18. Communiqué. Communiqué du Comité de l’Antibiogramme de la
Société Française de Microbiologie. Paris. [accessed April 2002].
Available from: http://www.sfm.asso.fr 
19. Satake S, Clark N, Rimland D, Nolte FS, Tenover FC. Detection of
vancomycin-resistant enterococci in fecal samples by PCR. J Clin
Microbiol 1997;35:2325–30.
20. Roger M, Faucher MC, Forest P, St-Antoine P, Coutlee F. Evaluation
of a vanA-specific PCR assay for detection of vancomycin-resistant
Enterococcus faecium during a hospital outbreak. J Clin Microbiol
1999;37:3348–9.
21. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide
resistance genotypes and identification to the species level of clinical-
ly relevant enterococci by PCR. J Clin Microbiol 1995;33:1434.
22. Lester S, Del Pilar Pla M, Wang F, Perez Schaeli I, O’Brien T. The
carriage of Escherichia coli resistant to antimicrobial agents by
healthy children in Boston, Caracas, Venezuela, and in Qin Pu, China.
N Engl J Med 1990;323:285–9.
23. Hennekens CH, Buring JE. Epidemiology in medicine. In: Cie Ba,
editor. Boston: Little, Brown; 1987. p. 77–96.
24. Glantz SA. Primer of biostatistics. New York: McGraw Hill;
1981:87–8.
25. Rothman KJ. No adjustments are needed for multiple comparisons.
Epidemiology 1990;1:43–6.
26. Savitz DA, Olshan AF. Multiple comparisons and related issues in the
interpretation of epidemiologic data. Am J Epidemiol 1995;
142:904–8.
27. Miller RG. Simultaneous statistical inference. Berlin: Springer
Verlag; 1981. p. 6–8.
28. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of
Staphylococcus aureus: epidemiology, underlying mechanisms, and
associated risks. Clin Microbiol Rev 1997;10:505–20.
29. Maiden MC. Horizontal genetic exchange, evolution, and spread of
antibiotic resistance in bacteria. Clin Infect Dis 1998;27(Suppl
1):S12–20.
30. Levy SB, Marshall B, Schluederberg S, Rowse D, Davis J. High fre-
quency of antimicrobial resistance in human fecal flora. Antimicrob
Agents Chemother 1988;32:1801–6.
31. Boisivon A, Thibault M, Leclercq R. Colonization by vancomycin-
resistant enterococci of the intestinal tract of patients in intensive care
units from French general hospitals. Clin Microbiol Infect
1997;3:175–9.
32. Use of antibiotics in animal feed. Official Journal of the European
Communities, editor. Friday 15 May 1998, Council resolution of 8
June 1999 on antibiotic resistance: a strategy against the microbial
threat. p. C195/1–3.
33. Boriès G, Louisot P. Rapport concernant l’utilisation d’antibiotiques
comme facteurs de croissance en alimentation animale: Mission
conjoine du Ministère Suédois de l’Agriculture, de la Pêche et de
l’Alimentation etdu Secrétariat à la Santé et à la Sécurité Sociale du
30 Mai 1997; 1998. Available from: http://www.agruculture.gouv.fr/
medi/edut/rapp-Boris.doc
34. Cremieux AC, Muller-Serieys C, Panhard X, Delatour F,
Tchimichkian M, Mentre F, et al. Emergence of resistance in normal
human aerobic commensal flora during telithromycin and amoxi-
cillin-clavulanic acid treatments. Antimicrob Agents Chemother
2003;47:2030–5.
35. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the
ecological balance of human microflora. Lancet Infect Dis
2001;1:101–4.
36. Fornasini M, Reves RR, Murray BE, Morrow AL, Pickering LK.
Trimethoprim-resistant  Escherichia coli in households of children
attending day care centers. J Infect Dis 1992;166:326–30.
37. DANMAP. Use of antimicrobial agents and occurrence of antimicro-
bial resistance in bacteria from food animals, food and humans in
Denmark. 2002. ISNN 1600-2032. Available from: http://www.
vetinst.dk
Address for correspondence: Antoine Andremont, Laboratoire de
Bactériologie, Groupe Hospitalier Bichat-Claude Bernard, 46 rue
Huchard - 75018 Paris, France; fax: 33 1 40 25 85 81; email:
antoine.andremont@bch.ap-hop-paris.fr
Antimicrobial Resistance in Pig Farmers
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 5, May 2004 879